文献速递神经肌肉病

杜氏肌营养不良症预期寿命:个体患者数据荟萃分析

Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis.
PubMed 文献 · Neurology · 2021-10-13

该研究系统检索截至2020年7月的杜氏肌营养不良症(DMD)死亡率文献,纳入14篇提供以年龄为时间轴的Kaplan-Meier生存曲线的出版物,数字化重建个体患者数据后进行汇总生存分析。共纳入2283例患者、其中1049例死亡,中位预期寿命为22.0年(95%CI 21.2–22.4);1990年后出生的患者中位预期寿命升至28.1年(95%CI 25.1–30.3)。

要点

  • DMD患者总体中位预期寿命为22.0年(95%CI 21.2–22.4)。
  • 1990年后出生患者中位预期寿命升至28.1年(95%CI 25.1–30.3)。
  • 缺乏大型前瞻性队列时,从文献提取个体患者数据可估算预期寿命。

核心结论

  • DMD患者中位预期寿命为22.0年(95%CI 21.2–22.4),且近几十年患者生存明显改善。
  • 1990年后出生的DMD患者中位预期寿命为28.1年(95%CI 25.1–30.3)。
  • 在缺乏大型前瞻性队列或试验死亡率数据时,从文献提取个体患者数据是估算DMD预期寿命的可行替代方法。

研究设计与样本

  • 系统综述截至2020年7月发表的DMD死亡率文献,重点纳入提供以年龄为时间轴的Kaplan-Meier生存曲线的出版物。
  • 共识别1177篇文章,14篇符合纳入标准,提供2283例患者数据,其中1049例死亡。
  • 对数字化重建的汇总个体患者数据采用Kaplan-Meier估计和参数生存分析模型分析,并按出生队列分层。

主要发现

  • 汇总个体患者数据的中位预期寿命为22.0年(95%CI 21.2–22.4)。
  • 按患者出生所处3个时间段分层分析显示,越近期患者群体预期寿命提高越明显。
  • 1990年后出生的患者中位预期寿命为28.1年(95%CI 25.1–30.3)。

临床怎么用

  • 可依据出生年代分层的预期寿命数据,为DMD患者及家庭提供预后咨询与长期照护规划。
  • 对1990年后出生的DMD患者,预后沟通中可参考中位预期寿命28.1年(95%CI 25.1–30.3)。
  • 在缺乏本地大型队列数据时,可参考本汇总个体患者数据估算DMD群体预期寿命。

局限性

  • 研究基于文献中Kaplan-Meier曲线的数字化重建个体患者数据,非原始前瞻性队列。
  • 符合纳入标准的文献仅14篇,DMD本身罕见、研究文献与患者数量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Duchenne muscular dystrophy (DMD) is a rare progressive disease that is often diagnosed in early childhood and leads to considerably reduced life expectancy; because of its rarity, research literature and patient numbers are limited. To fully characterize the natural history, it is crucial to obtain appropriate estimates of the life expectancy and mortality rates of patients with DMD. METHODS: A systematic review of the published literature on mortality in DMD up to July 2020 was undertaken, specifically focusing on publications in which Kaplan-Meier (KM) survival curves with age as a timescale were presented. These were digitized, and individual patient data (IPD) were reconstructed. The pooled IPD were analyzed with the KM estimator and parametric survival analysis models. Estimates were also stratified by birth cohort. RESULTS: Of 1,177 articles identified, 14 publications met the inclusion criteria and provided data on 2,283 patients, of whom 1,049 had died. Median life expectancy was 22.0 years (95% confidence interval [CI] 21.2, 22.4). Analyses stratified by 3 time periods in which patients were born showed markedly increased life expectancy in more recent patient populations; patients born after 1990 have a median life expectancy of 28.1 years (95% CI 25.1, 30.3). DISCUSSION: This article presents a full overview of mortality across the lifetime of a patient with DMD and highlights recent improvements in survival. In the absence of large-scale prospective cohort studies or trials reporting mortality data for patients with DMD, extraction of IPD from the literature provides a viable alternative to estimating life expectancy for this patient population.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Broomfield J, Hill M, Guglieri M, et al. Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis. Neurology. 2021. PMID: 34645707. doi:10.1212/WNL.0000000000012910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。